Hinchingbrooke Hospital is a small district general hospital in Hinchingbrooke near Huntingdon, Cambridgeshire. Opened in 1983, it serves the Huntingdonshire area, and has a range of specialities as well as an emergency department and a maternity unit.

There are 266 beds in Hinchingbrooke Hospital.

During the past decade, Hinchingbrooke Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hinchingbrooke Hospital" #1 sponsor was "Papworth Hospital NHS Foundation Trust" with 2 trials, followed by "Royal Marsden NHS Foundation Trust" with 2 trials sponsored, "Anglia Ruskin University" with 1 trials sponsored, "Belfast Health and Social Care Trust" with 1 trials sponsored and "Cambridge University Hospitals NHS Foundation Trust" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hinchingbrooke Hospital" #1 collaborator was "Anglia Ruskin University" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator, "Cancer Research UK" with 1 trials as a collaborator and "Hinchingbrooke Healthcare NHS Trust" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Hinchingbrooke Hospital" are "Breast Cancer" (4 trials), "Colorectal Cancer" (4 trials), "Cancer" (2 trials), "Colorectal Neoplasms" (2 trials) and "Lymphoma" (2 trials). Many other conditions were trialed in "Hinchingbrooke Hospital" in a lesser frequency.

Most popular intervention types in "Hinchingbrooke Hospital" are "Drug" (10 trials), "Other" (5 trials), "Biological" (4 trials), "Procedure" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (3 trials), "CHOP regimen" (2 trials), "doxorubicin hydrochloride" (2 trials), "vincristine sulfate" (2 trials) and "0.5 mg ranibizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hinchingbrooke Hospital" are 15 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Hinchingbrooke Hospital". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Hinchingbrooke Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hinchingbrooke Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".